Reviving Old Drugs with Specialty Intermediates in Europe
Drug development in the European pharmaceutical industry is undergoing a dramatic shift, largely due to the repurposing and reformulation of pre-existing chemicals rather than the discovery of novel molecules. Advances in specialty intermediates, which …